SBC Medical Group Holdings Inc
SBC Medical Group SBC | 0.00 |
SBC Medical Group Holdings Inc SBC.OQ SBC.O is expected to show a fall in quarterly revenue when it reports results on May 14 for the period ending March 31 2026
The Irvine California-based company is expected to report a 12.0% decrease in revenue to $41.655 million from $47.33 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for SBC Medical Group Holdings Inc is for earnings of 10 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for SBC Medical Group Holdings Inc is $8.50, about 169% above its last closing price of $3.16
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING |
STARMINESMARTESTIMATE® |
LSEG IBES ESTIMATE |
ACTUAL |
BEAT, MET, MISSED |
SURPRISE % |
Dec. 31 2025 |
0.12 |
0.12 |
0.14 |
Beat |
16.7 |
Sep. 30 2025 |
0.10 |
0.11 |
0.12 |
Beat |
9.1 |
Jun. 30 2025 |
0.14 |
0.14 |
0.02 |
Missed |
-85.2 |
Mar. 31 2025 |
0.11 |
0.11 |
0.21 |
Beat |
90.9 |
Dec. 31 2024 |
0.15 |
0.17 |
0.19 |
Beat |
11.8 |
Sep. 30 2024 |
2.36 |
2.36 |
0.03 |
Missed |
-98.7 |
This summary was machine generated May 12 at 13:38 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)